Bank of New York Mellon
PJP icon

Bank of New York Mellon’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bank of New York Mellon’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,483
Closed -$204K – 4334
2017
Q1 		$204K Buy
+3,483
New +$204K ﹤0.01% 3875

Other funds holding PJP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Bank of New York Mellon's PJP Position: Q2 2017 in Review

Bank of New York Mellon sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 3,483 shares — an estimated $204K sold.

Bank of New York Mellon first reported a position in PJP in Q1 2017 and held it in 1 quarter. The position peaked at $204K in Q1 2017. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

  • Bank of New York Mellon reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 3,483 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $204K.
  • Bank of New York Mellon first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and held it in 1 quarter.
  • Bank of New York Mellon's Invesco Pharmaceuticals ETF position peaked at $204K in Q1 2017.
  • 99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Bank of New York Mellon's 13F filing for Q2 2017, filed 3 Aug 2017.